ArticleScientific reports2025
Hybrid 3D-printed/electrospun scaffolds drive myogenic differentiation of mesenchymal stem cells (MSCs).
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- From molecular networks to the clinic: a systems biology-nanomedicine roadmap for osteoarthritis diagnosis, regeneration, and safety-by-design.Discover nano · 2026Review
- Manufacturing, Cell Regulation, and Coculture Strategies for Vascularization and Neural Innervation of Skeletal Muscle Tissue.Advanced healthcare materials · 2026Review
- Toward 4D Biomaterials: Comparing Electrospun and 3D-Printed Shape-Memory Scaffolds.Pharmaceutics · 2026Article
- Harnessing Lessons from Gel-Based and Advanced Biomaterial Therapeutics to Enable Direct Cellular Reprogramming.Gels (Basel, Switzerland) · 2026Review
- A Comprehensive Review on Food-Grade Electrospinning of Natural Biopolymers for Cultivated Meat Applications.Foods (Basel, Switzerland) · 2026Review
- The Synthetic Extracellular Matrix as a Maestro of the In Vitro Stem Cell Niche: Orchestrating Fate and Function.Biomedicines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The development of functional scaffolds that support cell differentiation and tissue regeneration remains a major challenge in regenerative medicine. In this study, we designed and fabricated hybrid scaffolds (HS) composed of poly(lactic-co-caprolactone) (PLA-PCL) by integrating 3D extrusion-based printing and electrospinning techniques. Two distinct 3D-printed architectures were explored-aligned filaments and grid patterns-which were subsequently coated with a layer of electrospun nanofibers to better mimic the anisotropic and hierarchical structure of native skeletal muscle tissue. Bone marrow porcine mesenchymal stem cells (p-MSCs) were seeded onto the scaffolds and cultured under myogenic conditions. To evaluate the progression of myogenic differentiation, we assessed the expression of early and late myogenic markers, MyoD and Myogenin respectively, at 14, 21 and 28 days. A comprehensive physical-mechanical characterization was performed, including morphological analysis, porosity measurements, and uniaxial tensile testing. The results demonstrated that the HS provided a biomimetic microenvironment that supported p-MSC attachment, viability, and differentiation. Notably, the HS aligned architecture enhanced the expression of myogenic markers compared to the grid design, suggesting a role of topographical cues in directing lineage commitment. These findings highlight the potential of dual-fabricated PLA-PCL scaffolds as a promising platform for guiding myogenic differentiation and may serve as a foundation for promoting functional skeletal muscle regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.